Emergent Biosolutions Inc (EBS) Stock Analysis

Emergent Biosolutions Inc (EBS) is a publicly traded company in the HEALTHCARE sector. It trades at $8.20, carries a market capitalization of $438.05M. This page summarizes the public market data, fundamentals, and frequently asked questions for EBS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NYSE

Key Metrics

Market Sentiment

Emergent Biosolutions Inc currently has a Bullish sentiment score of 0.44.

About Emergent Biosolutions Inc

Emergent BioSolutions Inc. (EBS), headquartered in Gaithersburg, Maryland, is a leading life sciences firm dedicated to enhancing public health preparedness through its comprehensive suite of innovative solutions tailored for both civilian and military applications. The company excels in the development and manufacturing of vaccines, therapeutics, and diagnostics designed to combat significant public health threats, including emerging infectious diseases and bioterrorism. With a robust produc...

GNG Research Analysis

GNG Research scores Emergent Biosolutions Inc (EBS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for EBS.

Frequently Asked Questions

Does EBS pay dividends?

Emergent Biosolutions Inc (EBS) does not currently pay a regular dividend.

What is EBS's market cap?

Emergent Biosolutions Inc (EBS) has a market capitalization of $438.05M with a current stock price of $8.20.